AI and Digital Leverage AI readiness benchmarking and InsightsEDGE Digital Twins to help life sciences clients accelerate AI adoption across commercial, value and access strategies, and payer engagement. Turn AI maturity insights into actionable roadmaps for optimizing pricing decisions and market access, while delivering measurable competitive differentiation.

Global Footprint With headquarters in New York, London and San Francisco, CBPartners can support multinational product launches with synchronized pricing, access and policy advisory across regions. The global footprint enables coordinated HTA preparation, regulatory alignment and regional market strategies while serving as a single partner for cross border programs.

Policy and HEOR A strong policy and HEOR orientation positions CBPartners to win business from government bodies, payers and biotech clients needing evidence generation and policy support. Active involvement in ISPOR and Prix Galien events provides access to influential networks for economic modeling, health outcomes research and payer communications.

Tech Leadership Recent CIO appointment and a technology driven service approach signal readiness for digital transformation projects. The firm can deploy robust data governance, analytics platforms and AI enabled pricing and access analytics to support clients commercialization and policy outcomes.

Growth Opportunity The current size and growth trajectory suggest opportunities to partner with small to mid size life sciences companies seeking integrated commercialization advice. A compelling combination of AI readiness, digital twins, policy advisory and regional capabilities enables cross selling across Value, Access and Pricing, Commercial Strategy and Government Policy services.